Trial Profile
A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2011
Price :
$35
*
At a glance
- Drugs PX 1041 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Pharmexa